|
Originally published In Press as doi:10.1074/jbc.M003934200 on May 24, 2000
J. Biol. Chem., Vol. 275, Issue 42, 32721-32727, October 20, 2000
Gram-negative Bacteria-binding Protein, a Pattern Recognition
Receptor for Lipopolysaccharide and -1,3-Glucan That Mediates the
Signaling for the Induction of Innate Immune Genes in Drosophila
melanogaster Cells*
Yong-Sik
Kim §,
Ji-Hwan
Ryu §¶,
Sung-Jun
Han **,
Kun-Ho
Choi ,
Ki-Bum
Nam ,
In-Hwan
Jang ¶,
Bruno
Lemaitre ,
Paul T.
Brey , and
Won-Jae
Lee §§
From the Laboratory of Immunology, BK21
Center for Medical Science and Medical Research Center, Yonsei
University College of Medicine, 134 Shinchon-dong, CPO Box
8044, Seoul, South Korea, the Laboratoire de Biochimie et
Biologie Moléculaire des Insectes, Institut Pasteur, 25, rue du
Dr. Roux, 75724 Paris, France, and the
 Centre de Génétique
Moléculaire, Centre National de la Recherche Scientifique, 91198 Gif-sur-Yvette, France
Received for publication, May 9, 2000
 |
ABSTRACT |
Pattern recognition receptors, non-clonal immune
proteins recognizing common microbial components, are critical for
non-self recognition and the subsequent induction of
Rel/NF- B-controlled innate immune genes. However, the molecular
identities of such receptors are still obscure. Here, we present data
showing that Drosophila possesses at least three cDNAs
encoding members of the Gram-negative bacteria-binding protein
(DGNBP) family, one of which, DGNBP-1, has been characterized.
Western blot, flow cytometric, and confocal laser microscopic analyses
demonstrate that DGNBP-1 exists in both a soluble and a
glycosylphosphatidylinositol-anchored membrane form in culture medium
supernatant and on Drosophila immunocompetent cells,
respectively. DGNBP-1 has a high affinity to microbial immune elicitors
such as lipopolysaccharide (LPS) and -1,3-glucan whereas no binding
affinity is detected with peptidoglycan, -1,4-glucan, or chitin.
Importantly, the overexpression of DGNBP-1 in Drosophila
immunocompetent cells enhances LPS- and -1,3-glucan-induced innate
immune gene (NF- B-dependent antimicrobial peptide gene)
expression, which can be specifically blocked by pretreatment with
anti-DGNBP-1 antibody. These results suggest that DGNBP-1 functions as
a pattern recognition receptor for LPS from Gram-negative bacteria and
-1,3-glucan from fungi and plays an important role in non-self
recognition and the subsequent immune signal transmission for the
induction of antimicrobial peptide genes in the Drosophila
innate immune system.
 |
INTRODUCTION |
The innate immunity in Drosophila is an efficient host
defense system aimed at preventing microbial infections (1-3). Upon microbial infection, insects rapidly recognize an invading pathogen as
non-self and synthesize a battery of innate immune genes such as
antimicrobial peptides (1-3). The induction of antimicrobial peptide
genes is regulated by Rel/NF- B factors in either
Toll-dependent and/or -independent Rel/NF- B signaling
pathways (4-7). In both signaling pathways, the activation of
Rel/NF- B factors is regulated by the Drosophila homolog
of the mammalian I B kinase (8). In mammals, pathogen-induced innate
immune signaling pathways are also achieved through Toll I B
kinase Rel/NF- B factors (9-14).
Although striking similarities have been observed between the
intracellular innate immune signaling pathways in insects and mammals
(1, 4, 8, 9, 15, 16), the recognition process for non-self remains a
challenging field in innate immune signal transduction. It has been
hypothesized that the innate immune system can detect invading
pathogens by virtue of "non-clonal pattern recognition receptors"
that interact with common microbial structures and deliver an immune
signal to the host cells (16, 17). In humans, distinct membrane
Toll-like receptors can directly bind common bacterial components such
as LPS,1 bacterial
lipoprotein, and peptidoglycan and subsequently initiate an
intracellular Rel/NF- B signaling pathway leading to innate immune
gene induction (9-13). In Drosophila, although Toll and the
related molecule 18-Wheeler are involved in the induction of
antimicrobial peptide genes (4, 18), Drosophila Toll does not function as a pattern recognition receptor (19). Instead of
microbial cell wall components, an active form of the spaetzle gene
product generated by the proteolytic cascade is thought to be the
extracellular ligand for Toll in the immune response (4, 19).
Recently several soluble recognition molecules including Gram-negative
bacteria-binding protein (20-22), peptidoglycan binding protein (23,
24), LPS-and -1,3-glucan binding protein (25, 26), and
-1,3-glucan recognition protein (27, 28) have been found in various
invertebrates and are proposed as pattern recognition receptors. The
key question, however, that remains is whether those soluble pattern
recognition molecules can truly mediate the induction of innate immune
genes in response to microbial infection or to the presence of
microbial cell wall components. In this study, we have addressed two
questions. First, do the membrane and/or soluble forms of pattern
recognition receptors exist in Drosophila immune cells? And
second, if so, do they transmit immune signaling across the membrane
for the induction of innate immune genes? To address these questions,
we have cloned three novel Drosophila Gram-negative
bacteria-binding proteins (DGNBPs) and showed that DGNBP-1 (i) exists
in both soluble and membrane-bound forms, (ii) is a pattern recognition
protein for specific microbial components, and (iii) mediates induction
of various B-dependent innate immune genes in response
to microbial challenges.
 |
EXPERIMENTAL PROCEDURES |
Insect Cell Culture--
Drosophila immunocompetent
Schneider cells (ATCC CRL-1963) and l(2)mbn cells were
maintained exactly as described previously (29). Stably transformed
cells expressing DGNBP-1 were maintained in the presence of 300 µg/ml hygromycin.
cDNA Cloning of DGNBP Family--
Except when specially
mentioned, all DNA and RNA manipulations were carried out using
standard techniques (30). With a synthetic primer pair (sense: 5'-ATG
CCA GGA TTG TGC ATT G-3'; antisense: 5'-GTC CAA AGG TAT AGA ACA TC-3')
derived from a Drosophila expressed sequence tag
(EST) clone (LD 15841) showing homology to the amino acid sequence of
Bombyx GNBP (20), we amplified and isolated a specific
300-base pair polymerase chain reaction (PCR) product from a
Drosophila l(2)mbn cDNA library (kindly provided from
Dr. D. Hultmark, University of Umeå, Sweden). The PCR fragment was used as a probe to screen a Zap II l(2)mbn cDNA
library. Partial sequences of two other DGNBPs (DGNBP-2 (GH 07433) and
DGNBP-3 (LP 05991)), deposited by the EST project (Berkeley
Drosophila Genome Project), were identified by BLAST
algorithm-based GenBankTM search using the DGNBP-1 full sequence. Full
cDNA sequences of DGNBPs were determined using an A.L.F. express
automatic sequencer (Amersham Pharmacia Biotech).
RT-PCR Analysis--
RT-PCR was performed exactly as described
previously (8). The sequences of the specific primers for each of the
GNBPs are the following: DGNBP-1, sense, 5'-CAC ACC GAC TGT GGA GCT CCT TG-3' and antisense, 5'-GGC TGC GCC AGA TCT TGA TAC-3'; DGNBP-2, sense,
5'-ATG AGG TGG GAA TTT CTG C-3' and antisense, 5'-TCA CCC TGG TTT CAC
TCT T-3'; DGNBP-3, sense, 5'-AAG GCT AAG ATC GAT GTT-3' and antisense,
5'-CGT CTT CGC GAT AAC CCA GTC-3'. We used an antibacterial cecropin
gene as a marker for immune-inducible genes and the constitutive -actin gene for an internal control.
Bacterial Expression and Polyclonal Antibody Production of the
DGNBP-1--
DGNBP-1 cDNA was digested with SacI and
PstI, which gave a 1.3-kilobase fragment (nucleotides
275-1582), which was used to produce histidine-tagged recombinant
protein according to the manufacturer's instructions (Qiagen). Rabbit
polyclonal antibody using recombinant protein was produced, and
specific anti-DGNBP-1 antibody was purified by affinity as
previously described (31).
Flow Cytometric Analysis and Confocal Laser Microscopy--
For
the detection of the membrane-bound form of endogenous DGNBP-1,
immunocompetent Schneider cells (2 × 106) were washed
three times with ice-cold phosphate-buffered saline (PBS) and incubated
in PBS containing 2% fetal bovine serum for 10 min at 4 °C. The
rabbit anti-DGNBP-1 antiserum was used at 1:100 dilution in PBS for 30 min at 4 °C. Secondary fluorescein isothiocyanate-conjugated goat
anti-rabbit antibody was used at 1:100 dilution in PBS for 1 h at
4 °C. After each antibody incubation, cells were washed three times
for 10 min with PBS at 4 °C. After final washing, cells were fixed
with 4% paraformaldehyde in PBS. Surface-stained cells were analyzed
by confocal microscopy (Leica) and FACScanTM flow cytometer supported
by Lysis II software (Becton Dickinson).
Overexpression of DGNBP-1 in Drosophila Cells--
The DGNBP-1
open reading frame was subcloned into pMT/V5 vector (pMT/V5-DGNBP-1)
under the control of the metallothionein promoter (Invitrogen). Cells
stably expressing DGNBP-1 were generated as described previously (8).
Expression was induced in pools of cells by addition of
CuSO4 to the culture medium at a final concentration of 500 µM as described previously (8). Cells were induced for
36 h before use. The DGNBP-1- C construct, a deletion
mutant lacking the last 10 amino acids in the COOH-terminal hydrophobic
tail was also constructed and used for the generation of a stable
cell line.
Phosphatidylinositol-specific Phospholipase C (PI-PLC) Treatment
of DGNBP-1-overexpressed Cells--
PI-PLC treatment was carried out
essentially as described previously (32). Briefly,
DGNBP-1-overexpressed cells (106) were washed three times
with ice-cold PBS and incubated at 30 °C for 1 h in 50 µl of
PBS with or without 1 unit of PI-PLC (Sigma). According to
manufacturer's information, one unit will liberate one unit of
acetylcholinesterase per min from a membrane-bound crude preparation at
pH 7.4 at 30 °C for 10 min. After brief centrifugation, an aliquot
(20 µl) of supernatant was subjected to Western blot analysis using
affinity-purified anti-DGNBP-1 antibody.
Northern Blot Analysis--
Cells were stimulated with either
LPS (10 µg/ml) or -1,3-glucan (10 µg/ml) for 3 h. Total RNA
extraction and Northern blot experiments were carried out as described
previously (20). The open reading frame regions of the cDNAs
encoding cecropin A1 (33), drosomycin (34), and attacin (35) were
amplified by PCR, and each amplified PCR product was used as probe. The
-actin cDNA was used as an internal standard probe (36). For
inhibition experiment by anti-DGNBP-1 antiserum, cells were pretreated
with either DGNBP-1 antiserum or pre-immune serum at the final
concentration of 1% for 1 h at room temperature before stimulation.
Binding Assay--
Curdlan ( -1,3-glucan), peptidoglycan
( -1,4-glycosidic linkage between N-acetylmuramic acid and
N-acetylglucosamine), chitin ( -1,4-N-actyl-D-glucosamine) and cellulose
( -1,4-glucan) were used for the in vitro binding assay of
DGNBP-1. One hundred µg of each insoluble polysaccharide was added in
300 µl of the supernatant of DGNBP-1 overexpressed stable cell line
or in 5 µg of purified DGNBP-1 and incubated at room temperature with
mild agitation for 1 h. The mixture was centrifuged (10,000 × g for 2 min) and the pellet was washed three times with 1 ml of washing buffer (10 mM Tris, pH 7.5, 500 mM NaCl, 0.02% Tween 20). The proteins bound on insoluble
polysaccharide were detached by adding SDS-polyacrylamide gel
electrophoresis sample buffer and analyzed by Western blot analysis
using affinity-purified anti-DGNBP-1 antibody. The LPS binding assay
was carried out by essentially the same method as described above
except the binding mixture was centrifuged at 20,000 × g for 10 min at each step to precipitate small particles of
LPS.
 |
RESULTS |
Structural Features and Expression Patterns of the DGNBP
Family--
To investigate the functional pattern recognition
receptor(s) in Drosophila immune system, we first
BLAST-searched the Drosophila database (BDGF
Drosophila Genome Project, Berkeley, CA) using the
NH2-terminal amino acid sequence of Gram-negative
bacteria-binding protein, a candidate immune recognition protein
originally identified in Bombyx mori (20). One positive
clone (DGNBP-1) was isolated from a Drosophila l(2)mbn cell
library as described under "Experimental Procedures." Sequencing
analysis showed that DGNBP-1 contains an open reading frame of 1482 nucleotides corresponding to 494 amino acids. Using an amino acid
sequence deduced from the full DGNBP-1 cDNA, we identified two
highly homologous partial sequences deposited in the
Drosophila EST database. The entire nucleotide sequences of
these two DGNBP homologs (DGNBP-2 and-3) were also determined. The
sequence alignment of the three newly cloned DGNBPs showed that DGNBP-1
shares 30 and 26% identity with DGNBP-2 and DGNBP-3, respectively
(Fig. 1A).

View larger version (78K):
[in this window]
[in a new window]
|
Fig. 1.
Structural feature of DGNBPs.
A, multiple alignment of DGNBPs. Identical amino acid
residues are boxed. The numbers to the right indicate amino
acid position of the encoded protein. B, multiple alignment
of the -1,3-glucanase homology domain of glucanase motif-containing
proteins. The numbers to the right indicate the initial
amino acid position to the last amino acid position of the glucanase
homology stretch of each protein. Glutamic acid residues corresponding
to the active site of the B. circulans -1,3-glucanase A1
are marked with asterisks. Ag-GNBP, A. gambiae GNBP (AJ001042); Bci-beta-gluc, B. circulans -1,3-glucanase A1 (P23903); Bm-beta-GRP,
B. mori -1,3-glucan recognition protein (AB026441);
Bm-GNBP, B. mori GNBP (L38591); CCF-1,
E. foetida coelomic cytolytic factor (AF030028);
DGNBP, D. melanogaster GNBP; Factor G,
T. tridentatus -1,3-glucan-sensitive coagulation factor G
-chain (D16622); LGBP, P. leniusculus LPS-and
-1,3-glucan-binding protein (AJ250128); Ms-GRP, M. sexta -1,3-glucan recognition protein (AF177982). The alignment
is optimized by introducing gaps ( ) using the Clustal W 1.7 program.
|
|
Furthermore, to facilitate future genetic analysis of these DGNBPs,
chromosomal localizations of DGNBPs were established from the
Drosophila Genome Database based on the known genes situated in the proximity of DGNBPs. DGNBP-1 and -2 were co-located at 74D-75C1
between ftz-f1 (74DS4-5) and term (75C1-2).
DGNBP-3 was found at 66E-F between dally (66E1) and
argk (66F1).
Interestingly, all DGNBPs contain a -1,3-glucanase-like domain
homologous to Bacillus circulans -1,3-glucanase (37)
(Fig. 1B). The two glutamic acid residues (Fig. 1B,
asterisks) correspond to active site residues in the glucanase
domain of B. circulans -1,3-glucanase. Like other insect
-1,3-glucanase-like domain-containing recognition proteins (20, 27,
28), these residues are altered in the DGNBPs, suggesting that DGNBPs
have lost glucanase activity. A sequence comparison of the
-1,3-glucanase homology domain of DGNBPs (Fig. 1B) with
known -1,3-glucanase domain-containing recognition protein family
shows that DGNBP-1 is most homologous to B. mori GNBP (20)
with 44% identity followed by DGNBP-2 with 40% identity,
Manduca sexta -1,3-glucan recognition protein ( GRP) (28) and B. mori GRP (27) with 39.5% identity, DGNBP-3
with 39% identity, Anopheles gambiae GNBP (21) with 33%
identity, LPS- and -1,3-glucan binding protein (LGBP) of
Pacifastacus leniusculus (26) with 32% identity, B. circulans -1,3-glucanase (37) with 32% identity, coelomic
cytolytic factor-1 (CCF-1) of Eisenia foetida (25) with 29%
identity, and Tachypleus tridentatus
-1,3-glucan-sensitive coagulation factor G -chain (38) with 23% identity.
To determine the transcriptional regulation of DGNBPs during
Drosophila development, we performed RT-PCR analysis using
total RNA isolated from different developmental stages utilizing
specific primer pairs for each DGNBP. The levels of mRNA encoding
each DGNBP were normalized in relation to the levels of control RNA encoding -actin. The expression of the DGNBP-1 gene was
detected throughout all Drosophila life stages from egg to
imago (Fig. 2A). However, the
mRNA of DGNBP-2 and -3 showed very weak signals during embryonic
development (Fig. 2A).

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 2.
Expression profiles of DGNBPs.
A, RT-PCR analysis of DGNBPs at different
Drosophila developmental stages. Total RNA from
Drosophila at several developmental stages was extracted and
used for RT-PCR analysis. B, RT-PCR analysis of DGNBP-1 in
immune-challenged Drosophila adults. Drosophila
male adults were unchallenged (lane 0), Escherichia
coli-challenged for 3, 6, and 12 h (lanes 3,
6, and 12, respectively) and Beauveria
bassiana-challenged for 36 h (lane B) as described
by Lemaitre et al. (42), and used for RT-PCR analysis.
C, RT-PCR analysis of DGNBPs in immunocompetent
Drosophila Schneider cells. Cells were treated with LPS (10 µg/ml) for 0, 3, 6, and 12 h.
|
|
We next examined the induction profile of DGNBP mRNA following
infection. A RT-PCR analysis for DGNBPs was performed using Drosophila adults and a Drosophila
immunocompetent Schneider and l(2)mbn cell line following a
bacterial challenge and fungal infection. We also performed RT-PCR for
a constitutively expressed -actin gene and an inducible
antibacterial cecropin A gene. No additional up-regulation was observed
following a microbial challenge, which demonstrated that endogenous
DGNBPs are constitutively transcribed in Drosophila adults
and immunocompetent Schneider cells (Fig. 2, B and
C). Similar expression profiles were obtained when we performed RT-PCR using l(2)mbn cells (data not shown). Under
the same conditions, the cecropin A gene is markedly induced.
Interestingly, we observed a significant down-regulation of DGNBPs
during the early phase (3-6 h) of bacterial infection (Fig. 2,
B and C).
DGNBP-1 Exists in Both a Soluble and Membrane-bound
Glycosylphosphatidylinositol (GPI)-anchored Form in Drosophila Cells,
and the COOH-terminal Hydrophobic Tail Is Necessary for Membrane
Localization--
DGNBPs have COOH-terminal hydrophobic tails
containing a putative GPI anchor attachment site, which suggests
the existence of a membrane-bound form. As membrane localization of the
recognition molecules is necessary for signal transmission across the
membrane of immune cells, we examined the cellular localization of
DGNBP-1 in immunocompetent Schneider cells. We first generated a
polyclonal antibody using bacterial-expressed DGNBP-1. Western blot
analysis showed that this antiserum specifically recognized an
endogenous polypeptide with an apparent molecular mass of 55 kDa in
Schneider cells whereas the pre-immune serum derived from the same
rabbit did not recognize this polypeptide (Fig.
3A). This antibody
specifically recognized recombinant DGNBP-1 but not recombinant DGNBP-2
or -3 (data not shown). With this specific anti-DGNBP-1 antiserum, we
used cell surface staining methods in a non-permeable condition. Flow
cytometric analysis and confocal laser microscopy showed that the
endogenous DGNBP-1 is located on the surface of the immunocompetent Schneider cells (Fig. 3, B-E).

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 3.
Localization of DGNBP-1. Normal
untransfected Schneider (A-E) cells and
DGNBP-1-overexpressed stable cell lines (F-H) were used for
the experiments. A, Western blot of Schneider cell lysates
using anti-DGNBP-1 antiserum (IS) or pre-immune serum
(PS). The molecular mass markers are indicated in kDa.
B, flow cytometric analysis of immunocompetent Schneider
cells stained by either pre-immune serum (PS) or
anti-DGNBP-1 antiserum (IS). C,
immunofluorescence detection of membrane-bound DGNBP-1 in
immunocompetent Schneider cells by anti-GNBP-1 antiserum. D,
control immunofluorescence detection by pre-immune serum. E,
serial section of DGNBP-1-stained cell. Eight serial sections
were obtained by confocal image analysis program. F,
Western blot analysis of membrane fraction of Schneider cells stably
expressing either DGNBP-1 wild type (DGNBP-1) or DGNBP
mutant form lacking COOH-terminal hydrophobic tail
(DGNBP-1- C). Cells were treated with or
without CuSO4 for 36 h, sonicated for 15 s, and
centrifuged at 20,000 × g for 10 min. The pellets
containing membrane fraction were washed and extracted with 8 M urea. Aliquots of membrane extracts were analyzed by
Western blot analysis. G, digestion of membrane-bound form
of DGNBP-1 by PI-PLC. Cells stably expressing DGNBP-1 were washed three
times with PBS and incubated with or without PI-PLC for 1 h at
30 °C. After centrifugation, supernatants were subjected to
Western blot analysis. H, detection of the soluble form of
DGNBP-1 in culture media. Cells (DGNBP-1) were incubated with or
without CuSO4 for 36 h. Supernatant (300 µl) was
concentrated by trichloroacetic acid precipitation and subjected to
Western blot analysis.
|
|
We next examined whether the COOH-terminal hydrophobic tail is
necessary for membrane localization of DGNBP-1. For this purpose, we
generated a cell line stably expressing a DGNBP-1- C mutant form
lacking the COOH-terminal hydrophobic tail (deletion of the last 10 amino acids). Overexpression of the DGNBP-1- C mutant was initiated
by adding CuSO4, and a membrane fraction was prepared. Western blot analysis showed that this DGNBP-1 mutant form was not
detected in the cell membrane fraction whereas the DGNBP-1 wild type
was detected in the membrane fraction of the CuSO4-induced cells (Fig. 3F). This result indicates that the
COOH-terminal hydrophobic tail is necessary for the normal membrane
localization of the DGNBP-1 protein.
To discern whether DGNBP-1 is GPI-anchored, we treated
DGNBP-1-overexpressed cells with PI-PLC. The proteins released from cells were subjected to Western blot analysis. The results indicate that DGNBP-1 can only be detected in the supernatant of cells treated
with PI-PLC, demonstrating that DGNBP-1 is a GPI-anchored membrane
protein (Fig. 3G).
In our previous study, Bombyx GNBP was purified as a soluble
form from the immunized hemolymph (20). It is possible that DGNBP-1
exists both as soluble and a GPI-anchored membrane-bound form. To
establish whether DGNBP-1 can also exist as a soluble form, we
generated a stable cell line under the control of a metallothionein promoter producing a wild-type GNBP-1 because of the small amount of
soluble DGNBP-1 produced in the medium of cultured cells. In the
copper-induced condition, we also detected a large amount of
overexpressed DGNBP-1 in the culture supernatant (Fig. 3H). These results show that DGNBP-1 exists both as a soluble and a GPI-anchored membrane-bound form in cultured Drosophila
immune cells.
DGNBP-1 Can Recognize the Pattern Motif of -1,3-Glucan and
LPS--
In the Drosophila innate immune system, as in the
human innate immune system, the pattern motifs of the microbial cell
wall components (such as LPS from Gram-negative bacteria, peptidoglycan from Gram-positive bacteria, and -1,3-glucan from yeast) can initiate innate immune signaling. To examine the binding specificity of
DGNBP-1 with these immune elicitors, we incubated various insoluble oligosaccharide polymers with DGNBP-1. Subsequent to washing as described under "Experimental Procedures," the proteins bound to
the precipitates were extracted with SDS-polyacrylamide gel electrophoresis sample buffer and analyzed by Western blot using affinity-purified anti-DGNBP-1 antibody. The results show that DGNBP-1
was specifically detected in the extract from the binding assay with
-1,3-glucan and LPS, whereas no binding activity was observed with
peptidoglycan, -1,4-glucan, or chitin (Fig.
4). Thus, the binding of DGNBP-1 to
-1,3-glucan and LPS seems to be specific.

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 4.
Binding activity of DGNBP-1. In
vitro binding assay was performed as described under
"Experimental Procedures" using various microbial immune elicitors
(peptidoglycan, -1,3-glucan, and LPS) and related polysaccharide
structures (cellulose and chitin). The molecular mass markers are
indicated in kDa.
|
|
Involvement of DGNBP-1 in the Induction of Innate Immune
Genes--
Given that DGNBP-1 can recognize LPS and -1,3-glucan
in vitro and that it is located on the membrane of
immunocompetent cells, the possible involvement of DGNBP-1 in the
induction of Drosophila Rel/NF- B-controlled innate immune
genes was investigated. For this purpose, we first generated a cell
line stably expressing DGNBP-1 under the control of a metallothionein
promoter and used this to analyze immune gene regulation. Following
-1,3-glucan or LPS stimulation, we used a Northern blot analysis
with specific probes for well known B-dependent
antimicrobial peptide genes (drosomycin, cecropin, and attacin). The
results demonstrate that when the DGNBP-1 is overexpressed, the immune
inducibility of all examined antimicrobial peptide genes was greatly
enhanced by 2-4 times over that of control cells (Fig.
5, A and B).
Similar results were obtained when we examined the time course
activation of antimicrobial gene expression (Fig. 5C). In
our previous report (8) and also in the control experiments,
CuSO4 treatment in the untransfected cells or cell line
stably expressing an unrelated Drosophila protein had no
noticeable effect on the immune inducibility of antimicrobial genes
(data not shown). These results show that DGNBP-1-overexpressed cells
are more responsive to LPS and -1,3-glucan for the induction of
innate immune genes, thereby indicating the involvement of DGNBP-1 in
the LPS or -1,3-glucan signal transduction pathway at least when
DGNBP-1 is overexpressed in Drosophila immune cells.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 5.
Enhanced inducibility of
Drosophila innate immune genes following
-1,3-glucan or LPS treatment in
DGNBP-1-overexpressed cells. A, Northern blot analysis
of innate immune gene expression. Cells stably expressing DGNBP-1 under
control of metallothionein promoter were treated with or without
CuSO4 (500 µM) for 36 h. Cells were then
incubated with -1,3-glucan (10 µg/ml) or LPS (10 µg/ml) for
3 h. The expression level of various innate immune genes was
measured by performing Northern blot analysis. B,
quantification of innate immune gene expression. The signals obtained
from Northern blot analysis were quantified by PhosphorImager (Fuji).
Signals for each antimicrobial peptide gene was normalized with the
corresponding value of -actin signals. In each antimicrobial peptide
gene, the expression level following -1,3-glucan or LPS treatment in
the absence of DGNBP-1 overexpression was taken arbitrarily as 100, and
the results are presented as relative expression. Each bar
represents the average of four independent experiments. C,
time course activation of cecropin and attacin genes in
DGNBP-1-overexpressed cells following LPS stimulation. Cells stably
expressing DGNBP-1 under control of metallothionein promoter were used
in this study. Cells were incubated in the absence or presence of
CuSO4 for 36 h and then incubated with or without LPS
(10 µg/ml) for 0, 3, 6, and 12 h. Northern blot analysis was
performed as described under "Experimental Procedures." Data are
representative from three independent experiments.
|
|
To see whether endogenous DGNBP-1 is indeed a pattern recognition
receptor for the transmission of NF- B signaling across the membrane,
we pretreated immunocompetent Schneider cells with monospecific DGNBP-1
antiserum to inhibit the binding capacity of endogenous DGNBP-1 prior
to LPS stimulation. Northern blot analysis was performed to measure
antimicrobial peptide gene expression in a DGNBP-1-antiserum-treated
condition and control pre-immune serum-treated condition. The results
show that the LPS-inducibility of attacin, cecropin, and drosomycin was
greatly impaired by pretreatment with DGNBP-1 antiserum but not by
pre-immune control serum (Fig. 6). This
suggests that endogenous DGNBP-1 is an essential signal transducer for
inducibility of innate immune genes in cultured Drosophila
immune cells.

View larger version (62K):
[in this window]
[in a new window]
|
Fig. 6.
LPS-induced up-regulation of innate immune
genes is inhibited by blocking of endogenous DGNBP-1.
Drosophila immunocompetent Schneider cells were treated with
either monospecific DGNBP-1 antiserum or control pre-immune serum for
1 h at room temperature prior to LPS stimulation (10 µg/ml for
3 h) Northern blot analysis was performed to measure antimicrobial
peptide gene expression. Data are representative from three independent
experiments.
|
|
 |
DISCUSSION |
The initiation of the innate immune system is an important means
of host defense in all eukaryotes (1, 39). Analysis of the regulation
of innate immune genes such as antimicrobial peptide genes in
Drosophila have been particularly fruitful and is providing
new directions for the analysis of the mammalian host defense system
(1, 39). It is now clear that the Toll receptor family, originally
identified in Drosophila dorsoventral development, mediates
the innate immune response through Rel/NF- B in insects and mammals
(4, 7, 9-14, 18). Although increasing amounts of information on the
intracellular signaling pathway leading to antimicrobial peptide gene
induction have been documented in Drosophila (1-8), no
pattern recognition protein directly involved in this signal
transduction has been reported. Because the recognition of microbial
cell wall components is an essential initial step for intracellular
innate immune signaling, we focused on the early recognition event of
the innate immune system.
In the present study, we have shown that DGNBP-1 specifically
recognizes common immune elicitors, such as LPS and -1,3-glucan. However, similar sugar motifs such as chitin and cellulose are not
efficient ligands for DGNBP-1. Thus, the binding specificity of DGNBP-1
seems to be restricted to a common structural motif between LPS and
-1,3-glucan. Previously, we observed that Bombyx GNBP
exclusively binds Gram-negative bacteria (20). In the case of
Anopheles GNBP, the binding specificity is unknown, but the induction of Anopheles GNBP mRNA is more responsive to
Gram-positive bacteria than to Gram-negative bacteria, and yeast is
ineffective as an inducer (21). Interestingly, Anopheles
GNBP is also up-regulated by the malaria parasite (22). These results
suggest that different members of the GNBP family may have different
recognition specificities for the recognition of diverse pathogens. It
is also possible that DGNBP-2 and DGNBP-3 have different pattern
recognition characteristics than DGNBP-1 and may serve in the
recognition of different microbial pathogens. Very recently, Ochiai and
Ashida (27) proposed the existence of more than two kinds of domains
together with the 100 amino acids of the NH2-terminal
region that are implicated in -1,3-glucan recognition of
-1,3-glucanase domain-containing recognition proteins. Thus, the
binding domain of -1,3-glucanase domain-containing recognition
proteins seems to be more complex than previously thought. More
extensive binding studies of the entire -1,3-glucanase
domain-containing recognition protein family will elucidate this issue.
For instance, the binding characteristics of DGNBP-1 are similar to
recently cloned -1,3-glucanase domain-containing soluble proteins
such as LGBP, CCF-1, and GRPs from different species of
invertebrates (25-28). These proteins are known to be involved in the
prophenoloxidase activation system, a constitutive immune cascade found
in body fluid (25-28). However, unlike these -1,3-glucanase
domain-containing recognition proteins, DGNBP-1 exists as both a
soluble and a GPI-anchored membrane-bound form in cultured
Drosophila immune cells. As the COOH-terminal is shown to be
important for the membrane attachment of DGNBP-1, soluble DGNBP-1 is
probably generated by a post-translation modification.
Pattern recognition receptors are required to possess at least two
sequential functional capacities for the correct initiation of the
innate immune system: (i) evaluate non-self pathogens by pattern
recognition capacities, and (ii) deliver a danger signal to immune
cells for de novo synthesis of innate immune molecules. No
such pattern recognition receptor has been described in
Drosophila or any other insect. We have shown that
overexpression of both forms of DGNBP-1 greatly enhances the immune
inducibility of antimicrobial peptide genes in response to LPS and
-1,3-glucan. Furthermore, blocking endogenous DGNBP-1 by the DGNBP-1
antibody inhibited the LPS-induced inducibility of antimicrobial
peptide genes. These results correlate well with our binding studies
and suggest that DGNBP-1 is a functional pattern recognition receptor
for LPS and -1,3-glucan, which plays the role of an immune-signaling
mediator across the cell membrane. However, at present we cannot
explain how the soluble and membrane-bound form of DGNBP-1, lacking a cytoplasmic signaling domain, intervenes in immune signal transmission for the induction of antimicrobial peptide genes. A similar situation was observed in the mammalian GPI-anchored CD14, a well known pattern
recognition molecule for LPS also lacking a cytoplasmic domain (40). In
the case of CD14, it serves as a co-receptor for the Toll-like receptor
in response to microbial infection (11, 41). The Toll-like receptor
contains a cytoplasmic domain homologous to the type-I
interleukin-1 receptor, which is essential for innate immune
signal transduction. Whether DGNBP-1 also synergistically cooperates
with other proteins containing a cytoplasmic domain (e.g.
Drosophila Toll/18-Wheeler or with other unknown receptors) for signal transmission remains to be determined.
In conclusion, our results suggest that DGNBP-1 is a functional pattern
recognition receptor for LPS and -1,3-glucan and mediates innate
immune signaling for the induction of antimicrobial peptide gene
induction in cultured Drosophila immune cells. To our
knowledge, this is the first report of an invertebrate pattern recognition protein directly involved in both recognition and transmission of intracellular immune signaling. More detailed in
vivo genetic studies will allow us to better understand the role(s) of pattern recognition receptors in the innate immune system in
Drosophila and perhaps in humans.
 |
ACKNOWLEDGEMENT |
We thank Dr. J.-K. Seong and the Biolink
Company for helping with the antibody production and Miss Y.-H. Kim for
excellent technical assistance.
 |
FOOTNOTES |
*
This work was supported in part by the Korea Research
Foundation, 1998 (to W.-J. L) and by the Pasteur Inst. (to P. T. B).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF228472 (DGNBP-1), AF228473 (DGNBP-2), and AF228474 (DGNBP-3).
§
The first two authors contributed equally to this work.
¶
Recipient of the Brain Korea 21 Program for Medical Science
from the Korea Ministry of Education.
**
Recipient of a French Government Scholarship.
§§
To whom correspondence should be addressed. Tel.: 82-23618339;
Fax: 82-23647364; E-mail: wjlee1@yumc.yonsei.ac.kr.
Published, JBC Papers in Press, May 24, 2000, DOI 10.1074/jbc.M003934200
 |
ABBREVIATIONS |
The abbreviations used are:
LPS, lipopolysaccharide;
GNBP, Gram-negative bacteria-binding protein;
PCR, polymerase chain reaction;
LGBP, LPS-and -1,3-glucan binding
protein;
CCF-1, coelomic cytolytic factor-1;
GRP, -1,3-glucan
recognition protein;
PBS, phosphate-buffered saline;
RT-PCR, reverse
transcription-PCR;
GPI, glycosylphosphatidylinositol;
PI-PLC, phosphatidylinositol-specific phospholipase C.
 |
REFERENCES |
| 1.
|
Hoffmann, J. A.,
Kafatos, F. C.,
Janeway, C. A., Jr.,
and Ezekowitz, R. A.
(1999)
Science
284,
1313-1318
|
| 2.
|
Hultmark, D.
(1993)
Trends Genet.
9,
178-183
|
| 3.
|
Engström, Y.
(1998)
in
Molecular Mechanisms of Immune Response in Insects
(Brey, P. T.
, and Hultmark, D., eds)
, pp. 211-244, Chapman and Hall Ltd., London
|
| 4.
|
Lemaitre, B.,
Nicolas, E.,
Michaut, L.,
Reichhart, J.-M.,
and Hoffmann, J. A.
(1996)
Cell
86,
973-983
|
| 5.
|
Wu, L. P.,
and Anderson, K. V.
(1998)
Nature
392,
93-97
|
| 6.
|
Meng, X.,
Khanuja, B. S.,
and Ip, Y. T.
(1999)
Genes Dev.
13,
792-797
|
| 7.
|
Lemaitre, B.,
Kromer-Metzger, E.,
Michaut, L.,
Nicolas, E.,
Meister, M.,
Georgel, P.,
Reichhart, J.-M.,
and Hoffmann, J. A.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
9465-9469
|
| 8.
|
Kim, Y.-S.,
Han, S.-J.,
Ryu, J.-H.,
Choi, K.-H.,
Hong, Y.-S.,
Chung, Y.-H.,
Perrot, S.,
Raibaud, A.,
Brey, P.-T.,
and Lee, W.-J.
(2000)
J. Biol. Chem.
275,
2071-2079
|
| 9.
|
Medzhitov, R.,
Preston-Hurlburt, P.,
and Janeway, C. A., Jr.
(1997)
Nature
388,
394-397
|
| 10.
|
Janeway, C. A., Jr.,
and Medzhitov, R.
(1999)
Curr. Biol.
9,
879-882
|
| 11.
|
Brightbill, H. D.,
Libraty, D. H.,
Krutzik, S. R.,
Yang, R. B.,
Belisle, J. T.,
Bleharski, J. R.,
Maitland, M.,
Norgard, M. V.,
Plevy, S. E.,
Smale, S. T.,
Brennan, P. J.,
Bloom, B. R.,
Godowski, P. J.,
and Modlin, R. L.
(1999)
Science
285,
732-736
|
| 12.
|
Schwandner, R.,
Dziarski, R.,
Wesche, H.,
Rothe, M.,
and Kirschning, C. J.
(1999)
J. Biol. Chem.
274,
17406-17409
|
| 13.
|
Cario, E.,
Rosenberg, I. M.,
Brandwein, S. L.,
Beck, P. L.,
Reinecker, H. C.,
and Podolsky, D. K.
(2000)
J. Immunol.
164,
966-972
|
| 14.
|
Rock, F. L.,
Hardiman, G.,
Timans, J. C.,
Kastelein, R. A.,
and Bazan, J. F.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
588-593
|
| 15.
|
O'Neill, L. A.,
and Greene, C.
(1998)
J. Leukocyte Biol.
63,
650-657
|
| 16.
|
Medzhitov, R.,
and Janeway, C. A., Jr.
(1997)
Cell
91,
295-298
|
| 17.
|
Janeway, C. A., Jr.
(1992)
Immunol. Today
13,
11-16
|
| 18.
|
Williams, M. J.,
Rodriguez, A.,
Kimbrell, D. A.,
and Eldon, E. D.
(1997)
EMBO J.
16,
6120-6130
|
| 19.
|
Levashina, E. A.,
Langley, E.,
Green, C.,
Gubb, D.,
Ashburner, M.,
Hoffmann, J. A.,
and Reichhart, J.-M.
(1999)
Science
285,
1917-1919
|
| 20.
|
Lee, W.-J.,
Lee, J.-D.,
Kravchenko, V. V.,
Ulevitch, R. J.,
and Brey, P. T.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
7888-7893
|
| 21.
|
Dimopoulos, G.,
Richman, A.,
Müller, H.-M.,
and Kafatos, F. C.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
11508-11513
|
| 22.
|
Richman, A. M.,
Dimopoulos, G.,
Seeley, D.,
and Kafatos, F. C.
(1997)
EMBO J.
16,
6114-6119
|
| 23.
|
Ochiai, M.,
and Ashida, M.
(1999)
J. Biol. Chem.
274,
11854-11860
|
| 24.
|
Kang, D.,
Liu, G.,
Lundstrom, A.,
Gelius, E.,
and Steiner, H.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
10078-10082
|
| 25.
|
Beschin, A.,
Bilej, M.,
Hanssens, F.,
Raymakers, J.,
Van Dyck, E.,
Revets, H.,
Brys, L,
Gomez, J.,
De Baetselier, P.,
and Timmermans, M.
(1998)
J. Biol. Chem.
273,
24948-24954
|
| 26.
|
Lee, S.-Y.,
Wang, R.,
and Soderhäll, K.
(2000)
J. Biol. Chem.
275,
1337-1343
|
| 27.
|
Ochiai, M.,
and Ashida, M.
(2000)
J. Biol. Chem.
275,
4995-5002
|
| 28.
|
Ma, C.,
and Kanost, M. R.
(2000)
J. Biol. Chem.
275,
7505-7514
|
| 29.
|
Han, S.-J.,
Choi, K.-Y.,
Brey, P. T.,
and Lee, W.-J.
(1998)
J. Biol. Chem.
273,
369-374
|
| 30.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, Cold Spring Harbor Press, Plainview, NY
|
| 31.
|
Harlow, E.,
and Lane, D.
(1988)
Antibodies: A Laboratory Manual
, Cold Spring Harbor Press, Plainview, NY
|
| 32.
|
Itoh, Y.,
Kajita, M.,
Kinoh, H.,
Mori, H.,
Okada, A.,
and Seiki, M.
(1999)
J. Biol. Chem.
274,
34260-34266
|
| 33.
|
Kylsten, P.,
Samakovlis, C.,
and Hultmark, D.
(1990)
EMBO J.
9,
217-224
|
| 34.
|
Fehlbaum, P.,
Bulet, P.,
Michaut, L.,
Lagueux, M.,
Broeckaert, W.,
Hertu, C.,
and Hoffmann, J.
(1994)
J. Biol. Chem.
269,
33159-33163
|
| 35.
|
Åsling, B.,
Dushay, M.,
and Hultmark, D.
(1995)
Insect Biochem. Mol. Biol.
25,
511-518
|
| 36.
|
Fyrberg, E. A.,
Bond, B. J.,
Hershey, N. D.,
Mixter, K. S.,
and Davidson, N.
(1981)
Cell
24,
107-116
|
| 37.
|
Yahata, N.,
Watanabe, T.,
Nakamura, Y.,
Yamamoto, Y.,
Kamimiya, S.,
and Tanaka, H.
(1990)
Gene (Amst.)
86,
113-117
|
| 38.
|
Seki, N.,
Muta, T.,
Oda, T.,
Iwaki, D.,
Kuma, K.,
Miyata, T.,
and Iwanaga, S.
(1994)
J. Biol. Chem.
269,
1370-1374
|
| 39.
|
Medzhitov, R.,
and Janeway, C. A., Jr.
(1998)
Curr. Opin. Immunol.
10,
12-15
|
| 40.
|
Pugin, J.,
Heumann, I. D.,
Tomasz, A.,
Kravchenko, V. V.,
Akamatsu, Y.,
Nishijima, M.,
Glauser, M. P.,
Tobias, P. S.,
and Ulevitch, R. J.
(1994)
Immunity
1,
509-516
|
| 41.
|
Yoshimura, A.,
Lien, E.,
Ingalls, R. R.,
Tuomanen, E.,
Dziarski, R.,
and Golenbock, D.
(1999)
J. Immunol.
163,
1-5
|
| 42.
|
Lemaitre, B.,
Reichhart, J.-M.,
and Hoffmann, J. A.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
14614-14619
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Gonzalez, Y. Gueguen, D. Destoumieux-Garzon, B. Romestand, J. Fievet, M. Pugniere, F. Roquet, J.-M. Escoubas, F. Vandenbulcke, O. Levy, et al.
Evidence of a bactericidal permeability increasing protein in an invertebrate, the Crassostrea gigas Cg-BPI
PNAS,
November 6, 2007;
104(45):
17759 - 17764.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-W. Park, C.-H. Kim, J.-H. Kim, B.-R. Je, K.-B. Roh, S.-J. Kim, H.-H. Lee, J.-H. Ryu, J.-H. Lim, B.-H. Oh, et al.
Clustering of peptidoglycan recognition protein-SA is required for sensing lysine-type peptidoglycan in insects
PNAS,
April 17, 2007;
104(16):
6602 - 6607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. W. T. Chan, C. G. Howes, and L. J. Foster
Quantitative Comparison of Caste Differences in Honeybee Hemolymph
Mol. Cell. Proteomics,
December 1, 2006;
5(12):
2252 - 2262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Dinglasan and M. Jacobs-Lorena
Insight into a Conserved Lifestyle: Protein-Carbohydrate Adhesion Strategies of Vector-Borne Pathogens
Infect. Immun.,
December 1, 2005;
73(12):
7797 - 7807.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. W. Kim, Y.-J. Kwon, J. M. Kim, Y.-H. Song, S. N. Kim, and Y.-J. Kim
MED16 and MED23 of Mediator are coactivators of lipopolysaccharide- and heat-shock-induced transcriptional activators
PNAS,
August 17, 2004;
101(33):
12153 - 12158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Osta, G. K. Christophides, D. Vlachou, and F. C. Kafatos
Innate immunity in the malaria vector Anopheles gambiae: comparative and functional genomics
J. Exp. Biol.,
July 1, 2004;
207(15):
2551 - 2563.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|